Edesa Biotech, Inc. (EDSA) Stock Overview
Explore Edesa Biotech, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Edesa Biotech, Inc. (EDSA)
Key Financials
Key Financials
Market Cap
24.1M
P/E Ratio
-1.29
EPS (TTM)
$-1.69
ROE
-1.24%
EDSA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Edesa Biotech, Inc. (NASDAQ: EDSA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Edesa Biotech, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of EDSA on the NASDAQ shows an RSI of 27.71, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $8.67 for the NASDAQ listing.
Key metrics behind Edesa Biotech, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.29 and a market capitalization of 24.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of EDSA on the NASDAQ.